// STATE LEGISLATION TRACKER

Ohio SB 230 — Authorize pharmacists to test, treat certain health conditions

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Unknown

State: Ohio
Bill: SB 230
Filed: 2025-07-07
Read the bill: OpenStates →
Last reviewed: 2026-06-21

Plain-English Summary

Ohio SB230 appears to authorize pharmacists to test and treat certain health conditions. Based on the available title and metadata, it does not appear to address compounded peptides, off-label prescribing, telehealth peptide care, FDA 503A/503B compounding, controlled substances, or prescription monitoring.

Key Points

No clear impact on access to compounded peptides
No clear change to off-label peptide prescribing
No clear change to NP or naturopathic peptide care
No clear change to 503A or 503B compounding rules

What to Watch For

Note Watch for bill text to confirm which health conditions pharmacists could test and treat.

Note If amendments add prescribing, compounding, or controlled-substance language, peptide relevance could change.

Where the Bill Stands

The provided source says the latest action could not be refetched, so the bill's current legislative status is unclear.

— Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-06-21 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws